Botulinum toxin management of adductor spasmodic dysphonia with vocal tremors

Nan Mai Wang*, Chin Song Lu

*Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

2 Scopus citations

Abstract

A prospective nonrandomized study of 9 patients undergoing their first treatment for adductor spasmodic dysphonia (ADSD) at Chang Gung Memorial Hospital, Taiwan, provided the data discussed here. The investigation had a twofold purpose: (a) to assess phonation outcomes of Botox injections given to the patients with ADSD, with and without vocal tremors, comparing the outcomes between the two groups, and (b) to discuss the clinical implications of the phonatory outcomes.

Original languageEnglish
Pages (from-to)1-8
Number of pages8
JournalJournal of Medical Speech-Language Pathology
Volume12
Issue number1
StatePublished - 03 2004
Externally publishedYes

Fingerprint

Dive into the research topics of 'Botulinum toxin management of adductor spasmodic dysphonia with vocal tremors'. Together they form a unique fingerprint.

Cite this